T. Wagner

发表

Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

F. Couch, B. Karlan, J. Klijn, 2007, Breast Cancer Research and Treatment.

Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations inBRCA1

E. Ostrander, P. Devilee, S. Tavtigian, 2001, Journal of medical genetics.

Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.

F. Couch, T. Rebbeck, R. Eeles, 2007, Clinical breast cancer.

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

F. Couch, O. Olopade, J. Klijn, 2002, Journal of the National Cancer Institute.

Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.

O. Olopade, T. Rebbeck, R. Eeles, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

F. Couch, O. Olopade, B. Karlan, 2006, JAMA.

Triggering of Suicidal Erythrocyte Death by Gefitinib

F. Lang, H. Cao, T. Wagner, 2017, Cellular Physiology and Biochemistry.

Hereditary Breast and Ovarian Cancer: Structures of Care in Austria

E. Kubista, T. Wagner, D. Muhr, 2006, Breast Care.

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

F. Couch, O. Olopade, J. Klijn, 2002, Journal of the National Cancer Institute.

Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.

P. Møller, W. Foulkes, C. Isaacs, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCAmutations

P. Oefner, T. Helbich, T. Wagner, 2000, British Journal of Cancer.

Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations.

J. Attems, E. Kubista, C. Singer, 2007, Endocrine-related cancer.

Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers

F. Couch, O. Olopade, J. Klijn, 2005, International journal of cancer.

Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group.

P. Oefner, T. Helbich, T. Wagner, 2000, British journal of cancer.

Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype

Julian Peto, Ute Hamann, Peter Devilee, 2005, Clinical Cancer Research.

New Austrian mutation in BRCA1 gene detected in three unrelated HBOC families

H. Breiteneder, T. Wagner, O. Scheiner, 1996, The Lancet.

Magnetic Resonance Imaging of the Breast Improves Detection of Invasive Cancer, Preinvasive Cancer, and Premalignant Lesions during Surveillance of Women at High Risk for Breast Cancer

T. Helbich, Michael Weber, M. Fuchsjäger, 2007, Clinical Cancer Research.

A Comparison of Bilateral Breast Cancers in BRCA Carriers

O. Olopade, P. Møller, W. Foulkes, 2005, Cancer Epidemiology Biomarkers & Prevention.

Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers

J. Klijn, D. Easton, B. Weber, 2004, Clinical Cancer Research.

Contributions of ATM mutations to familial breast and ovarian cancer.

P. Oefner, Kristine M. Yu, G. Chu, 2003, Cancer research.

Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations.

P. Oefner, T. Wagner, T. Sandberg, 1999, Genomics.

Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.

T. Rebbeck, J. Klijn, P. Møller, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Defect of Tumour Necrosis Factor-α (TNF-α) Production and TNF-α-induced ICAM-1 – Expression in BRCA1 Mutations Carriers

E. Kubista, R. Wolfram, C. Wiltschke, 2003, Breast Cancer Research and Treatment.

AURKA F31I Polymorphism and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Consortium of Investigators of Modifiers of BRCA1/2 Study

R. Vierkant, T. Sellers, V. Pankratz, 2007, Cancer Epidemiology Biomarkers & Prevention.

AURKA F 31 I Polymorphism and Breast Cancer Risk in BRCA 1 and BRCA 2 Mutation Carriers : A Consortium of Investigators of Modifiers of BRCA 1 / 2 Study

R. Vierkant, T. Sellers, J. Olson, 2007 .

Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Dieter Niederacher, Ute Hamann, Alfons Meindl, 2008, American journal of human genetics.

RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.

F. Couch, O. Olopade, T. Rebbeck, 2007, American journal of human genetics.

P. Oefner, T. Helbich, Å. Borg, 1998, International journal of cancer.

Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations.

P. Underhill, P. Shen, P. Oefner, 1999, Human molecular genetics.

Surgical breast lesions in adolescent females

E. Kubista, T. Wagner, M. Tea, 2008, Pediatric Surgery International.

Rapid progression of prostate cancer in men with a BRCA2 mutation

P Ghadirian, F. Couch, D. Horsman, 2008, British Journal of Cancer.

The validity of complex breast cysts after surgery.

E. Kubista, C. Grimm, T. Wagner, 2007, American journal of surgery.

The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group.

M. Beckmann, T. Sellers, M. Stratton, 2000, American journal of human genetics.

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers

Jan Lubinski, Fergus Couch, Ping Sun, 2008, International journal of cancer.

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.

O. Olopade, T. Rebbeck, R. Eeles, 2006, The Lancet. Oncology.

Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group.

J. Chang-Claude, D. Easton, A. Antoniou, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non‐Ashkenazi Jewish women with familial breast and ovarian cancer

P. Oefner, M. Papa, R. Hofstra, 2000, Human mutation.

Are ATM Mutations 7271T→G and IVS10-6T→G Really High-Risk Breast Cancer-Susceptibility Alleles?

J. Houwing-Duistermaat, J. Klijn, A. Broeks, 2004, Cancer Research.

Defect of tumour necrosis factor-alpha (TNF-alpha) production and TNF-alpha-induced ICAM-1-expression in BRCA1 mutations carriers.

E. Kubista, R. Wolfram, C. Wiltschke, 2003, Breast cancer research and treatment.

Younger birth cohort correlates with higher breast and ovarian cancer risk in European BRCA1 mutation carriers

P. Oefner, F. Frommlet, E. Kubista, 2005, Human mutation.

Central European BRCA2 mutation carriers: birth cohort status correlates with onset of breast cancer.

P. Oefner, C. Singer, T. Wagner, 2014, Maturitas.

Synchrotron X-ray study at Trieste: No correlation between breast cancer and hair structure

H. Amenitsch, S. Bernstorff, M. Rappolt, 1999 .

Prenatal testing for late-onset diseases such as mutations in the breast cancer gene 1 (BRCA1). Just a choice or a step in the wrong direction?

T. Wagner, R. Ahner, Teresa M. U. Wagner, 1998, Human reproduction.

Founding BRCA1 mutations in Austrian HBOC families

P. Underhill, E. Kubista, H. Breiteneder, 1997 .

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

F. Couch, O. Olopade, J. Klijn, 2002, Journal of the National Cancer Institute.